BACKGROUND: To discuss risk factors for ovarian metastasis in a transposed ovary in patients treated for cervical cancer. CASES: Cases were two patients with ovarian metastasis in a transposed ovary in a series of 107 patients. These two patients were treated for a Stage IB squamous cell cervical cancer and presented with a tumor devoid of extrauterine spread (absence of nodal involvement or distant metastases) but with involvement of the uterine corpus. Furthermore, lymphovascular space involvement (LVSI) in the cervix or paracervix was present in both patients. CONCLUSIONS: Ovarian transposition should be performed in patients < or =40 years of age with a small invasive cervical carcinoma (< 3 cm) treated by primary surgery. This procedure should not be performed in patients with bulky tumor and/or in patients with LVSI. (c)2001 Elsevier Science.
BACKGROUND: To discuss risk factors for ovarian metastasis in a transposed ovary in patients treated for cervical cancer. CASES: Cases were two patients with ovarian metastasis in a transposed ovary in a series of 107 patients. These two patients were treated for a Stage IB squamous cell cervical cancer and presented with a tumor devoid of extrauterine spread (absence of nodal involvement or distant metastases) but with involvement of the uterine corpus. Furthermore, lymphovascular space involvement (LVSI) in the cervix or paracervix was present in both patients. CONCLUSIONS: Ovarian transposition should be performed in patients < or =40 years of age with a small invasive cervical carcinoma (< 3 cm) treated by primary surgery. This procedure should not be performed in patients with bulky tumor and/or in patients with LVSI. (c)2001 Elsevier Science.
Authors: Sana M Salih; Samet Albayrak; Songwon Seo; Sarah L Stewart; Kristen Bradley; David M Kushner Journal: J Reprod Med Date: 2015 Jul-Aug Impact factor: 0.142